Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/1999
08/31/1999US5945443 Kappa agonist compounds and pharmaceutical formulations thereof
08/31/1999US5945440 Indolocarbazole imides and the use thereof
08/31/1999US5945435 Levobupivacaine and its use
08/31/1999US5945426 Derivatives of pyrimidine for treating acute cerebrovascular disorders
08/31/1999US5945417 Nervous system disorders
08/31/1999US5945408 Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
08/31/1999US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent
08/31/1999US5945310 DNA encoding members of the IL-1 family, IL-1 delta
08/31/1999US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases
08/31/1999US5945123 Determining known pharacokinetic parameters of therapeutical substance, number of doses to be administered during 24 hours and determining time at which dose will be adminstered by considering both schedule and physiological anamolies
08/31/1999US5945119 A plastic strip having microporous material impregnated with cesium chloride and magnesium sulfate on both side as antiarthritic agent or treatment of other soft tissue injuries; antiinflammatory agents
08/31/1999US5944021 Therapeutic use of a carbonic anhydrase enzyme inhibitor for the treatment of brain edema
08/31/1999CA2183315C Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
08/31/1999CA2183314C Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
08/31/1999CA2163216C Anxiolytic agent
08/31/1999CA2006028C Cosmetic or pharmaceutical composition containing polymers or fatty bodies microspheres with at least one active ingredient
08/26/1999WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR
08/26/1999WO1999042574A1 Sequences of an ih ionic channel and the use thereof
08/26/1999WO1999042485A1 Mucilage, a g-protein-coupled receptor
08/26/1999WO1999042465A2 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
08/26/1999WO1999042458A1 Histamine h3 receptor ligands
08/26/1999WO1999042456A2 Novel compounds and their use as positive ampa receptor modulators
08/26/1999WO1999042444A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments
08/26/1999WO1999042443A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
08/26/1999WO1999042123A1 Method of promoting neuronal cell proliferation and diffrentiation
08/26/1999WO1999042108A1 Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system
08/26/1999WO1999042105A1 Epimorphian compound and its use
08/26/1999WO1999042102A1 Indole-3-propionic acids, salts and esters thereof used as medicaments
08/26/1999WO1999042095A1 Pharmaceutical combinations containing tramadol
08/26/1999WO1999042089A2 Use of thiadiazolo[4,3-a]pyridine derivatives
08/26/1999WO1999032606A3 Neural precursor cells, method for the production and use thereof in neural defect therapy
08/26/1999WO1999028342A3 Low-voltage activated calcium channel compositions and methods
08/26/1999WO1999024462A3 Novel conjugates of rgd-containing peptides and endogenous carriers
08/26/1999WO1999024421A8 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
08/26/1999DE19907493A1 Recombinant nucleic acid encoding modified forms of peptides involved in neurodegenerative diseases, useful for identifying potential therapeutic agents
08/26/1999DE19807979A1 New water-soluble dendrimeric fullerene derivatives, useful as neuroprotective and radical scavenging drugs
08/26/1999DE19807535A1 Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying
08/26/1999DE19807423A1 New isoindolone derivatives useful as soluble guanylate cyclase activators for treating cardiovascular disorders, asthma, renal insufficiency, diabetes, cirrhosis or cognitive dysfunction
08/26/1999CA2321498A1 Pharmaceutical preparations for the selectively supplementing oestrogen deficiency in the central nervous system
08/26/1999CA2321278A1 Novel compounds
08/26/1999CA2320354A1 Novel compounds and their use as positive ampa receptor modulators
08/26/1999CA2318959A1 Epimorphian compound and its use
08/26/1999CA2318836A1 Histamine h3 receptor ligands
08/26/1999CA2318237A1 Use of thiadiazolo[4,3-a]pyridine derivatives
08/25/1999EP0937777A2 GABA receptors and their uses
08/25/1999EP0937722A1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors
08/25/1999EP0937715A1 Tetrahydrobenzindole compounds
08/25/1999EP0937708A2 sulphonamide derivatives
08/25/1999EP0937458A2 Pyrrolidine and piperidine derivatives
08/25/1999EP0937143A2 Secreted proteins and polynucleotides encoding them
08/25/1999EP0937103A2 Compounds and methods for modulating cell adhesion
08/25/1999EP0937077A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
08/25/1999EP0937076A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
08/25/1999EP0937072A1 THIENYLCYCLOHEXANONE DERIVATIVES AS LIGANDS OF THE GABA A? $g(a)5 RECEPTOR SUBTYPE
08/25/1999EP0937069A1 Piperazino derivatives as neurokinin antagonists
08/25/1999EP0937065A1 Constrained somatostatin agonists and antagonists
08/25/1999EP0937064A1 Substituted oximes derivatives useful as neurokinin antagonists
08/25/1999EP0937062A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/25/1999EP0937061A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/25/1999EP0937060A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/25/1999EP0937059A1 NOVEL $i(TRANS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/25/1999EP0937058A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/25/1999EP0937057A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
08/25/1999EP0937053A1 Sustained-release derivatives of hydroxylated analogs of substituted 1- 2 bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake
08/25/1999EP0937047A1 1-arylphthalazine antagonists of excitatory amino acid receptors
08/25/1999EP0937045A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
08/25/1999EP0937043A1 Novel substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them
08/25/1999EP0937038A1 Vitamin d analogues
08/25/1999EP0937032A1 Substituted gamma aminobutyric acids as pharmaceutical agents
08/25/1999EP0936924A2 Pharmaceutical composition containing a 5ht 2c? antagonist and a d 2? antagonist
08/25/1999EP0936919A2 VARIANTS OF HUMAN CILIARY NEUROTROPHIC FACTOR (hCNTF) WITH A RANGE OF ACTION DIFFERENT FROM THAT OF THE WILD-TYPE MOLECULE
08/25/1999EP0700290B1 Rectal compositions containing odansetron in its free base form
08/25/1999EP0650483B1 (3R,4R)-$g(D)?6 -TETRAHYDROCANNABINOL-7-OIC ACIDS
08/25/1999EP0612321B1 Pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity
08/25/1999EP0237545B2 Production of pluripotent granulocyte colony-stimulating factor
08/25/1999CN1226929A Valtage-gated calcium channel antagonist and methods
08/25/1999CN1226893A Selected derivatives of K-252a
08/25/1999CN1226828A Treatment of psychotic disorders
08/25/1999CN1226824A Tramadol multiple unit formulations
08/25/1999CN1226803A Diphenyl heterocycles as potassium channel modulators
08/24/1999US5942540 Methods of providing symptomatic and prophylactic neuroprotection
08/24/1999US5942537 Administering a l-trans pyrrolidine derivative to inhibit the transport of l-glutamate or l-aspartate or an excitatory amino acid neurotransmitter away from a synapse comprising contacting synapse with pyrrolidine derivative
08/24/1999US5942536 Useful for treating migraine
08/24/1999US5942535 a!-Annelated pyrrole derivatives and pharmaceutical use thereof
08/24/1999US5942530 Method for treating pain
08/24/1999US5942529 Benzisothiazolyl-substituted aminomethylchromans
08/24/1999US5942526 5-acyl-1,4-dihydropyridines
08/24/1999US5942524 Serotonin(5-ht-1) agonists
08/24/1999US5942523 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
08/24/1999US5942517 Antagonist of alpha(1c) receptors; treatment of benign prostatic hyperplasia
08/24/1999US5942513 Administering with diuretic suppresses efflux of antagonist through the blood-brain barrier increasing the duration of action and magnitude of effect of antagonist; treatment of stroke, schizophrenia, anxiety; antiepileptic agents
08/24/1999US5942512 Method and composition for treating erectile dysfunction
08/24/1999US5942507 Furan nitrone compounds
08/24/1999US5942506 1- 2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives
08/24/1999US5942503 Use of Epinastine for the treatment of pain
08/24/1999US5942497 Purine compound and catecholamine compound containing compositions and methods for administration
08/24/1999US5942419 RsbW-1 encoding nucleic acids
08/24/1999US5942416 Treatment of infections from bacteria using polypeptides and polynucleotides
08/24/1999US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation
08/24/1999US5942400 Assays for detecting β-secretase
1 ... 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 ... 1833